Diagnosys LLC specializes in advanced visual function testing technologies, offering a comprehensive suite of systems designed for both preclinical and clinical applications. Their flagship product, the Preclinical Celeris, utilizes innovative dual function stimulator-electrodes to enhance rodent testing, while their electroretinography (ERG) solutions cater to a range of animal sizes. The company provides a variety of visual function tests, including visual electrophysiology, visual psychophysical assessments, objective acuity tests, and pupillometry, which collectively deliver a thorough evaluation of visual capabilities. This extensive range of testing options positions Diagnosys as a leader in the field, supporting researchers and clinicians in understanding and diagnosing visual impairments.

In addition to their testing systems, Diagnosys offers trial services that encompass study setup assistance, training, and data review, ensuring consistent and high-quality data collection across global research sites. Their commitment to in-house design of hardware and software allows for tailored solutions that meet both their specifications and those of their clients. The company’s patented platforms are recognized for their broad applicability in research and clinical settings, facilitating collaboration between academic institutions and patient clinics. With over forty years of experience, Diagnosys has established a strong network within the electrophysiology community, enhancing their ability to support advancements in visual function research and therapy development.

United States

We manufacture Vision electrophysiology testing equipment for detecting eye diseases and sold mainly to hospital and eye doctors. Based in the USA, we create the leading solutions for electrophysiology for all your needs in hospitals, research and drug trials

Diagnosys LLC

Company Details